Biomaterial Database

Some biochemical characteristics of species of the genus Beauveria. 1977

A Capek, and O Fassatiová

UI	MeSH Term	Description	Entries
D011374	Progesterone	The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.	Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D002384	Catalysis	The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.	Catalyses
D003904	Mitosporic Fungi	A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.	Deuteromycetes,Deuteromycota,Fungi imperfecti,Fungi, Mitosporic,Hyphomycetes,Deuteromycete,Deuteromycotas,Fungi imperfectus,Fungus, Mitosporic,Hyphomycete,Mitosporic Fungus,imperfectus, Fungi
D006651	Histocytochemistry	Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods.	Cytochemistry
D000935	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.	Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001711	Biotransformation	The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

A Capek, and O Fassatiová

[Biochemical characteristics of the genus Providencia].

January 1953, Annales de l'Institut Pasteur de Lille,

A Capek, and O Fassatiová

[Characteristics of some physiologic-biochemical properties of various representatives of the genus Micromonospora].

December 1974, Antibiotiki,

A Capek, and O Fassatiová

[Characteristics of some species of microorganisms related to the genus of hemoglobinophils].

August 1975, Zhurnal mikrobiologii, epidemiologii i immunobiologii,

A Capek, and O Fassatiová

[Biological and biochemical characteristics of a new pathogenic species of the genus Aleurisma].

January 1951, Bulletin de l'Academie nationale de medecine,

A Capek, and O Fassatiová

Antigenic relationships among pathogenic Beauveria bassiana with Engyodontium album (= B. alba) and non-pathogenic species of the genus Beauveria.

January 1997, Mycopathologia,

A Capek, and O Fassatiová

[Biochemical characterization of species in the genus Listeria].

October 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,

A Capek, and O Fassatiová

Cultural and biochemical characteristics of the genus Chromobacterium.

August 1956, Journal of general microbiology,

A Capek, and O Fassatiová

[Comparative study of some physiological-biochemical properties of Candida robusta and species of the genus Saccharomyces].

January 1962, Mikrobiologiia,

A Capek, and O Fassatiová

[Some biochemical pecularities of bacteria of the genus Pseudomonas].

January 1968, Mikrobiolohichnyi zhurnal,

A Capek, and O Fassatiová

[ALKALOIDS IN SOME SPECIES OF THE CORYDALIS GENUS].

February 1964, Meditsinskaia promyshlennost' SSSR,